203 related articles for article (PubMed ID: 7258018)
41. [Reactivity of rats inoculated intravenously with the L-phase variants of erysipelothrix rhusiopathiae].
Toshkov A; Noeva K; Todorov T; Slavcheva E; Georgiev D
Acta Microbiol Virol Immunol (Sofiia); 1977; 5():5-11. PubMed ID: 610402
[No Abstract] [Full Text] [Related]
42. Hyaluronidase is not essential for the lethality of Erysipelothrix rhusiopathiae infection in mice.
Shimoji Y; Asato H; Sekizaki T; Mori Y; Yokomizo Y
J Vet Med Sci; 2002 Feb; 64(2):173-6. PubMed ID: 11913558
[TBL] [Abstract][Full Text] [Related]
43. Properties of a protective protein antigen of Erysipelothrix rhusiopathiae.
Timoney JF; Groschup MM
Vet Microbiol; 1993 Nov; 37(3-4):381-7. PubMed ID: 8116193
[TBL] [Abstract][Full Text] [Related]
44. Comparison of etiological and immunological characteristics of two attenuated Erysipelothrix rhusiopathiae strains of serotypes 1a and 2.
Watarai M; Sawada T; Nakagomi M; Amao H; Yoshida T; Takahashi I
J Vet Med Sci; 1993 Aug; 55(4):595-600. PubMed ID: 8399739
[TBL] [Abstract][Full Text] [Related]
45. Characterization of protective antigen CbpB as an adhesin and a plasminogen-binding protein of Erysipelothrix rhusiopathiae.
Zhu W; Cai C; Li J; Zhang Q; Huang J; Jin M
Res Vet Sci; 2019 Jun; 124():352-356. PubMed ID: 31060015
[TBL] [Abstract][Full Text] [Related]
46. Characterization of a monoclonal antibody for in vitro potency testing of erysipelas bacterins.
Henderson LM; Jenkins PS; Scheevel KF; Walden DM
Dev Biol Stand; 1996; 86():334. PubMed ID: 8785974
[No Abstract] [Full Text] [Related]
47. [Protective medium for the lyophilization of a live vaccine against swine erysipelas--VR2].
Khristova Kh; Ninov NV; Dilovska Kh
Vet Med Nauki; 1984; 21(7-8):57-61. PubMed ID: 6506460
[TBL] [Abstract][Full Text] [Related]
48. Erysipelothrix rhusiopathiae infection of a total knee arthroplasty an occupational hazard.
Traer EA; Williams MR; Keenan JN
J Arthroplasty; 2008 Jun; 23(4):609-11. PubMed ID: 18514883
[TBL] [Abstract][Full Text] [Related]
49. Antibody activities of IgM and IgG fractions from rabbit anti-Erysipelothrix rhusiopathiae sera.
Yokomizo Y; Isayama Y
Res Vet Sci; 1972 May; 13(3):294-6. PubMed ID: 5043134
[No Abstract] [Full Text] [Related]
50. [Immunocytoadherence in acute experimental Erysipelothrix insidiosa infection in rats].
Slavcheva E; Nikolov P; Ilieva K
Acta Microbiol Virol Immunol (Sofiia); 1976; 3():20-3. PubMed ID: 1007948
[No Abstract] [Full Text] [Related]
51. Natural resistance to infection in the neonatal sheep: comparison of the ability of colostrum-deprived, normally-suckled and passively-immunized lambs to localize Erysipelothrix rhusiopathiae.
Piercy DW
Res Vet Sci; 1974 Sep; 17(2):210-4. PubMed ID: 4214281
[No Abstract] [Full Text] [Related]
52. Characterization of a protective protein antigen of Erysipelothrix rhusiopathiae.
Groschup MH; Cussler K; Weiss R; Timoney JF
Epidemiol Infect; 1991 Dec; 107(3):637-49. PubMed ID: 1752312
[TBL] [Abstract][Full Text] [Related]
53. Evaluation of Erysipelothrix rhusiopathiae vaccines in pigs by intradermal challenge and immune responses.
Vet Microbiol; ; . PubMed ID: 16678363
[TBL] [Abstract][Full Text] [Related]
54.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
55.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
56.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
57.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
58.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
59.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
60.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
